So, you're wondering why Bloom Energy Corp (BE) shares are having a good day? It's a simple story, really: artificial intelligence needs electricity. A lot of it. And it needs it right now, not whenever the local utility gets around to upgrading the grid.
That's where Bloom comes in. The company makes solid oxide fuel cells—basically boxes that generate electricity on-site, 24/7. They're fuel-flexible, running on natural gas, biogas, or hydrogen. For data centers racing to build out AI capacity, waiting for the traditional power grid to catch up isn't an option. Bloom is positioning its technology as a primary power source for these next-gen facilities, and the market is taking notice.
The fundamental story here is pretty strong. The company just posted record revenue of $2.02 billion for 2025. More impressively, its product backlog recently jumped 140% year-over-year to $6 billion. The total backlog, when you include everything, is now sitting near a whopping $20 billion. Management is guiding for 2026 revenue to come in between $3.1 billion and $3.3 billion. That's not just hopeful thinking; it's a backlog talking.
On the trading side, short interest has ticked down slightly. It fell to 22.04 million shares in the latest reporting period from 22.47 million, which represents about 10.43% of the public float. With an average daily trading volume of 10.11 million shares, it would take short sellers roughly 2.18 days to cover their bets if they had to scramble.
All eyes are now on the next financial update, scheduled for April 29. The consensus estimates are looking for earnings per share of 7 cents, up from 3 cents a year ago, and revenue of $520.35 million, a big jump from $326.02 million last year.
The analyst community is generally bullish. The stock carries a Buy rating with an average price target of $92.78. But some recent moves show even more optimism: Citigroup (C) initiated coverage with a Neutral rating but a $162 target back in February. Mizuho (MFG) has a Neutral but raised its target to $110. And JP Morgan (JPM) is Overweight with a target of $166.
Put it all together—the AI power demand, the massive backlog, the growth guidance, and the analyst support—and you get a stock that's up over 63% year-to-date. On Wednesday, shares were up another 4.61%, trading around $161.10.














